↓ Skip to main content

Cochrane Database of Systematic Reviews

Fluphenazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, August 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

blogs
2 blogs
policy
1 policy source
twitter
8 X users
wikipedia
7 Wikipedia pages

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
106 Mendeley
Title
Fluphenazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia
Published in
Cochrane database of systematic reviews, August 2014
DOI 10.1002/14651858.cd009230.pub2
Pubmed ID
Authors

Magdolna Tardy, Maximilian Huhn, Rolf R Engel, Stefan Leucht

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
South Africa 1 <1%
Unknown 105 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 18%
Student > Bachelor 15 14%
Researcher 9 8%
Other 7 7%
Student > Doctoral Student 6 6%
Other 16 15%
Unknown 34 32%
Readers by discipline Count As %
Medicine and Dentistry 28 26%
Psychology 12 11%
Nursing and Health Professions 9 8%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Unspecified 2 2%
Other 10 9%
Unknown 40 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2024.
All research outputs
#1,774,530
of 26,067,272 outputs
Outputs from Cochrane database of systematic reviews
#3,657
of 13,184 outputs
Outputs of similar age
#17,171
of 242,694 outputs
Outputs of similar age from Cochrane database of systematic reviews
#62
of 236 outputs
Altmetric has tracked 26,067,272 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,184 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.3. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,694 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 236 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.